Natera Announces Data from the ProActive Study that Supports Prospera Kidney as an Early Indicator of Transplant Rejection
05.06.2023 - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced new data on its Prospera test being presented at the American Transplant Congress (ATC) 2023 taking place June 3-7, 2023. The presentations include several ... Seite 1
Source: wallstreet-online.de